X
INO icon

Xponance’s Inovio Pharmaceuticals INO Stock Holding History

Xponance’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,178
Closed -$11.6K – 1273
2023
Q1 		$11.6K Hold
1,178
– – ﹤0.01% 1227
2022
Q4 		$22K Buy
1,178
+27
+2% +$612 ﹤0.01% 1213
2022
Q3 		$24K Buy
1,151
+162
+16% +$4.15K ﹤0.01% 1177
2022
Q2 		$21K Buy
+989
New +$27.9K ﹤0.01% 1180
2021
Q3 		– Sell
-943
Closed -$105K – 1206
2021
Q2 		$105K Buy
+943
New +$90.6K ﹤0.01% 1210

Other funds holding INO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Xponance's INO Position: Q2 2023 in Review

Xponance sold out of Inovio Pharmaceuticals (INO) in Q2 2023, closing a stake of 1,178 shares — an estimated $11.6K sold.

Xponance first reported a position in INO in Q2 2021 and held it in 5 quarters. The position peaked at $105K in Q2 2021. 133 funds tracked by Wall St. Rank hold INO as of Q2 2023.

  • Xponance reported no remaining Inovio Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Xponance sold 1,178 Inovio Pharmaceuticals shares in Q2 2023, an estimated $11.6K.
  • Xponance first reported a position in Inovio Pharmaceuticals in Q2 2021 and held it in 5 quarters.
  • Xponance's Inovio Pharmaceuticals position peaked at $105K in Q2 2021.
  • 133 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2023.

Based on Xponance's 13F filing for Q2 2023, filed 14 Jul 2023.